Sonoma Biotherapeutics Expands Series A Financing to $70 Million and Appoints Key Executives to Advance Regulatory T-cell Therapies in Autoimmune and Degenerative Diseases

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/2HCPTAC
via IFTTT